Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Ultragenyx Pharmaceutical Inc. | Financial_Report.xls |
| 10-K - 10-K - Ultragenyx Pharmaceutical Inc. | rare-10k_20141231.htm |
| EX-32.1 - EX-32.1 - Ultragenyx Pharmaceutical Inc. | rare-ex321_2014123125.htm |
| EX-31.1 - EX-31.1 - Ultragenyx Pharmaceutical Inc. | rare-ex311_2014123123.htm |
| EX-31.2 - EX-31.2 - Ultragenyx Pharmaceutical Inc. | rare-ex312_2014123124.htm |
| EX-10.34 - EX-10.34 - Ultragenyx Pharmaceutical Inc. | rare-ex1034_201412311155.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3ASR No. 333-201838) of Ultragenyx Pharmaceutical Inc., and
(2) Registration Statement (Form S-8 No. 333-201843 and 333-194773) pertaining to the 2011 Equity Incentive Plan, as amended, 2014 Incentive Plan and 2014 Employee Stock Purchase Plan of Ultragenyx Pharmaceutical Inc.; of our report dated March 27, 2015, with respect to the financial statements of Ultragenyx Pharmaceutical Inc. included in this Annual Report (Form 10-K) of Ultragenyx Pharmaceutical Inc. for the year ended December 31, 2014.
/S/ ERNST & YOUNG LLP
Redwood City, California
March 27, 2015